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The biosynthesis and secretion of crZmacroglobulin was studied in rat hepatocyte primary cultures. After 
immunoprecipitation of a2-macroglobulin from a cell homogenate and the hepatocyte medium, two forms 
of cr2-macroglobulin with app. h4, of 176000 and 182000, respectively, were identified. A precursor- 
product relationship for the two crZmacroglobulin forms was demonstrated by a pulse-chase xperiment. 
The cellular form of a2-macroglobulin could be deglycosylated by endoglucosaminidase H, whereas the 
medium form of aZmacroglobulin remained unaffected. On the other hand, only the medium form of 
cu2-macroglobulin was found to be susceptible to neuraminidase. In vitro translation of rat liver poly(A)+ 
RNA resulted in a translation product of an app. MI of 162000. 
cr2Macroglobulin Rat hepatocyte 
1. INTRODUCTION 
cuZMacroglobulin is an acute phase protein in 
the rat. Its biosynthesis increases markedly after 
inflammatory stimuli [1,2]. It is believed that 
a2-macroglobulin is synthesized in the liver and 
secreted into the blood [3,4], where it functions as 
an inhibitor of plasma endopeptidases. Unlike 
most other protein inhibitors of proteinases 
a2-macroglobulin inhibits by entrapping the pro- 
teinase molecules through a conformational 
change in the inhibitor [5]. Rat aZmacroglobulin 
is thought to consist of 4 probably identical sub- 
units of A4, of -180000-190000 each [5]. It has 
been found that rat aZmacroglobulin is a glyco- 
protein containing - 16% of carbohydrate [6-81. 
At present little information is available on the 
mechanism(s) of biosynthesis of au2macroglobulin. 
Here, hepatocytes, as well as cell-free systems 
have been used to learn more about the biosyn- 
thesis of auZmacroglobulin. It will be shown that 
two forms of cYZmacroglobulin exist: an intra- 
cellular mannose-rich, and an extracellular com- 
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plex-type glycoprotein. The cell-free translation of 
full sized a2-macroglobulin will be presented. 
2. MATERIALS AND METHODS 
L-[35S]Methionine (> 600 Ci/mmol), D-[2-3H]- 
mannose (13 Ci/mmol) and L-[5,6-3H]fucose 
(45 Ci/mmol) were purchased from the Radio- 
chemical Centre (Amersham). D-[6-3H]Galactose 
(15 Ci/mmol) was obtained from New England 
Nuclear (Boston). Endoglucosaminidase H from 
Streptomyces griseus H12 was purchased from 
Seikagaku Kogyo (Tokyo). Neuraminidase from 
Vibrio cholerae and tunicamycin were from 
Calbiochem-Behring (Giessen). Protein A-Sepha- 
rose CL4B was from Pharmacia (Freiburg). The 
preparation of rat hepatocytes and the labeling 
conditions with [35S]methionine and the 3H-labeled 
sugars were described in [9, lo]. The experimental 
details for the immunoprecipitation of cu2-macro- 
globulin, the binding conditions of the crZmacro- 
globulin antibody complexes to protein A-Sepha- 
rose, the conditions for polyacrylamide slab-gel 
electrophoresis and subsequent fluorography have 
been described in [9,10]. 
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2.1. Treatment of a2-macroglobulin with 
glycosidases 
The cr2-macroglobulin-IgG complexes eluted 
from the protein A-Sepharose were exhaustively 
dialyzed against 50 mM phosphate buffer (Na+) 
(pH 6.0), containing 0.01% sodium dodecyl 
sulfate. Incubation of radioactively-labeled 
cu2-macroglobulin obtained from one dish was car- 
ried out in 0.1 ml of the same buffer with 5 munits 
of endoglucosaminidase H at 37°C for 16 h. The 
incubation with neuraminidase was done in 50 mM 
sodium acetate buffer (pH 5.5), 0.15 M NaCl and 
9 mM CaC12 at 37°C for 16 h. 
2.2. Cell-free synthesis of aZmacroglobulin 
Male Wistar rats, kindly provided by Professor 
Dr H. Ueberberg (Thomae GmbH, Biberach), 
were injected intramuscularly with 0.5 ml turpen- 
tine/100 g body weight. The animals were killed 
18 h after injection and starvation, and the RNA 
was extracted with guanidinium HCl from the 
livers frozen in liquid nitrogen [ll]. Oligo(dT)- 
cellulose chromatography was used for the isola- 
tion of poly(A)+ RNA which then was translated 
into proteins in the presence of a rabbit reticulo- 
cyte lysate [ 121. RNase inhibitor purified from 
human placenta [13] was routinely added to the 
translation mixture of 1 unit/& 
3. RESULTS AND DISCUSSION 
3.1. Synthesis of a2-macroglobulin by rat 
hepatocytes 
Hepatocyte primary cultures were pulse-labeled 
with [35S]methionine for 10 min followed by a 
chase with unlabeled methionine. At different 
times ranging from lo-120 min, cells were 
separated and centrifuged. cYZMacroglobulin was 
immunoprecipitated from the supernatant obtain- 
ed from the homogenate or from the medium. It 
can be seen particularly from lanes 7 and 8 of fig. 1 
that two forms of cyZmacroglobulin, which differ 
slightly in their electrophoretic mobilities, are pre- 
sent in the hepatocytes, whereas the hepatocyte 
medium contains only the &Zmacroglobulin 
species with the higher app. M,. From a plot of the 
electrophoretic mobilities vs log M,, app. Mr of 
182000 and 176000 were estimated for the medium 
and cellular forms of cuZmacroglobulin, respec- 
tively. The a2-macroglobulin form - secreted by 
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Fig. 1. Synthesis and secretion of cu2-macroglobulin after 
pulse-labeling with [35S]methionine. Rat hepatocyte 
primary cultures were incubated with [35S]methionine 
(25 &i/dish) for 10 min followed by a chase with 
unlabeled methionine at a final concentration of 3 mM. 
cuZMacroglobulin was immunoprecipitated from the 
cells for 10 min (lane l), 30 min (lane 3), 60 min (lane 5), 
90 min (lane 7), 120 min (lane 9), and from the medium 
for 10 min (lane 2), 30 min (lane 4), 60 min (lane 6), 
90 min (lane 8) and 120 min (lane 10) after the chase. 
The following A4, markers were used: myosin from rab- 
bit muscle (205000), rat plasma cu2-macroglobulin 
(182000), conalbumin (86000), bovine serum albumin 
(68000) and catalase (60000). 
the hepatocytes - exhibits the same mobility dur- 
ing electrophoresis as the cYZmacroglobulin 
purified from rat plasma. Fig. 1 shows that between 
60 (lane 6) and 90 min (lane 8) after the chase, 
aZmacroglobulin appeared in the medium. A 
precursor-product relationship between the two 
a2-macroglobulin forms, characterized by dif- 
ferent M,, seems evident from these findings. 
Further evidence for the existence of two forms 
of c2-macroglobulin of different app. M, was ob- 
tained from digestion experiments of a2-macro- 
globulin from cells and from medium with endo- 
glucosaminidase H and neuraminidase, respective- 
ly. Fig.2 shows the results of the endoglucos- 
aminidase H treatment. Whereas the cellular 
a2-macroglobulin form was susceptible to endo- 
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Fig.2. Deglycosylation of cu2-macroglobulin with endo- 
glucosaminidase H. Rat hepatocyte primary cultures 
were incubated in medium containing [35S]methionine 
(25 &i/dish). After 2 h cu2-macroglobulin was immuno- 
precipitated from the cells (lanes 1,3) as well as from the 
medium (lanes 2,4), incubated without (lanes 1,2), or 
with 5 munits of endoglucosaminidase H (lanes 3,4) at 
37°C for 16 h as described in section 2. Tunicamycin was 
given to the hepatocyte culture medium at 3 pg/ml. 
After 1 h the medium was changed and medium contain- 
ing [3’S]methionine and tunicamycin at 3 pg/ml was 
given to the cell cultures. After a labeling time of 2 h, 
a2-macroglobulin was immunoprecipitated from the 
cells (lane 5). M, markers: cu2-macroglobulin from rat 
plasma (182000), conalbumin (86000), and bovine 
serum albumin (68000). 
glucosaminidase H (lane 3), the medium form of 
cuZmacroglobulin was unaffected (lane 4). The 
cuZmacroglobulin polypeptide obtained after 
1 2 3 4 5 
Fig.3. Treatment of cr2-macroglobulin with neur- 
aminidase. After a 2-h labeling period with 
[35S]methionine a2-macroglobulin was immunopre- 
cipitated from the cells (lanes 1,2) and from the medium 
(lanes 4,5), and incubated without (lanes 1,4), or with 
(lanes 2,5) 10 munits of neuraminidase from K cholerae 
at 37°C for 16 h as described in section 2. cu2-Macro- 
globulin immunoprecipitated from hepatocytes after 
tunicamycin treatment as described in fig.2 (lane 3). M, 
markers: ayZmacroglobulin from rat plasma (182000), 
conalbumin (86000), bovine serum albumin (68000), 
catalase (60000) and ovalbumin (43000). 
endoglucosaminidase H treatment of the cellular 
cuZmacroglobulin exhibited an increased electro- 
phoretic mobility, but different from that of 
czZmacroglobulin immunoprecipitated from 
hepatocytes after incubation with tunicamycin 
(lane 5), which blocks the formation of N-aspar- 
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agine-linked oligosaccharide chains. This dif- 
ference in M, might be due to the fact that endo- 
glucosaminidase H leaves the first N-acetylglucos- 
amine molecule of each oligosaccharide chain at- 
tached to asparagine. As shown in fig.3 the 
cuZmacroglobulin medium form, resistant to the 
action of endoglucosaminidase H, was susceptible 
to neuraminidase (lanes 4,5) indicating sialic acid 
to be a terminal sugar of the oligosaccharide 
chains. The neuraminidase digestion led to an 
a2-macroglobulin of slightly higher electrophoretic 
mobility corresponding to an app. Mr of - 174000. 
In addition, it can be seen in fig.3 that the faint 
band above the auZmacroglobulin cellular form 
(lane 1) - representing the cuZmacroglobulin 
medium form in the cells before secretion - disap- 
peared after digestion with neuraminidase (lane 2). 
In further experiments we have studied the in- 
corporation of radioactively-labeled mono- 
saccharides into cy2-macroglobulin. We found that 
[3H]mannose was predominantly incorporated into 
the intracellular cy2-macroglobulin form, whereas 
[3H]galactose and [3H]fucose were nearly ex- 
clusively incorporated into the medium form of 
a2-macroglobulin. These data will be published 
elsewhere. 
From the findings described, it can be concluded 
that au2macroglobulin is first synthesized as a 
mannose-rich glycoprotein, which then is trans- 
formed to a complex-type glycoprotein. Only the 
latter form is secreted. Similar observations have 
been made recently in the case of al-antitrypsin 
P,lOl. 
3.2. Synthesis of cu2-macroglobulin vitro 
Poly(A)-rich RNA, isolated from livers of tur- 
pentine-treated rats by guanidinium HCl extrac- 
tion, was translated into proteins using a rabbit 
reticulocyte lysate. The translation products label- 
ed with [%]methionine were treated with an anti- 
serum against rat cuZmacroglobulin. The fluoro- 
gram (fig.4) shows that a polypeptide of an app. 
Mr of 162000 had been synthesized. The yield of 
the in vitro synthesized aZmacroglobulin can be 
increased at least 5-fold by the use of RNase in- 
hibitor purified from human placenta [13]. When 
unlabeled cuZmacroglobulin was added in increas- 
ing concentrations to the translation mixture (lanes 
2-5) a competition was observed. No competition 
was found with rat serum albumin used as a con- 
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Fig.4. Cell-free synthesis of cu2-macroglobulin. Poly(A)- 
rich RNA from rat liver was translated in a cell-free 
system in vitro, immunoprecipitated, separated by 
sodium dodecyl sulfate polyacrylamide slab gel electro- 
phoresis and analyzed by autoradiography: lane 1, 
cuZmacroglobulin synthesized in vitro; lanes 2-6, same 
as lane 1, except hat 0.5 pg (lane 2), 1.5 fig (lane 3), 3 ag 
(lane 4), and 8 /g (lane 5) of rat plasma cu2-macro- 
globulin, and 8 pg of rat serum albumin (lane 6) have 
been added to the translation mixture before immuno- 
precipitation and sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis. The protein M, markers were 
myosin (205 000), Lu2-macroglobulin from rat plasma 
(182000), B’-subunit (165000), and P-subunit (155000) 
of RNA polymerase of E. coli, conalbumin (86000), 
bovine serum albumin (68000), catalase (60000), 
ovalbumin (43000) and alcohol dehydrogenase (37000). 
trol (lane 6). Since aZmacroglobulin is a secretory 
protein, and since, with a few exceptions [14-171, 
the in vitro synthesized secretory proteins are made 
as larger Mr precursors with N-terminal extensions, 
it is likely that a2-macroglobulin is also made as a 
larger M, precursor. The comparison with the 
mature, unglycosylated a2-macroglobulin isolated 
from tunicamycin-treated hepatocytes did not 
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show a difference in electrophoretic mobilities 
(lane 7). Due to the high M, of UuZmacroglobulin 
it is clear that our separation system is hardly 
suited to resolve small M, differences of 
2000-3000, which would be expected for 
aZmacroglobulin and an cu2-macroglobulin 
precursor carrying a signal peptide of about 20 
amino acids. Radioactive Edman degradation is in 
progress to solve this problem. 
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